These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2523644)

  • 21. A randomized comparison of isradipine slow release given once daily with isradipine twice daily on 24 hour blood pressure in hypertensive patients.
    Christensen HR; Kampmann JP; Simonsen K
    J Hum Hypertens; 1991 Apr; 5(2):121-7. PubMed ID: 1830108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time course of the blood pressure response to oral isradipine in uncomplicated mild-to-moderate essential hypertension.
    Leary WP; Reyes AJ; Maharaj B; van der Byl K
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):147S-150S. PubMed ID: 1827006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability of the new calcium antagonist isradipine in essential hypertension.
    Kirch W; Burger KJ; Weidinger G; Welzel D
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S55-9. PubMed ID: 1695304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicentre isradipine dose-confirmation study in Thai patients with hypertension.
    Tanomsup S; Tantbirojn P; Koanantakul B; Nontakanun S; Jaroonvesama N; Charoenlarp K
    Drugs; 1990; 40 Suppl 2():22-5. PubMed ID: 2150635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal and hemodynamic effects of isradipine in essential hypertension.
    Persson B; Andersson OK; Wysocki M; Hedner T; Aurell M
    Am J Med; 1989 Apr; 86(4A):60-4. PubMed ID: 2523657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium antagonists as first-line antihypertensive agents: a placebo-controlled, comparative trial of isradipine and nifedipine.
    Welzel D; Burger KJ; Weidinger G
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S70-4. PubMed ID: 1695308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An acute dose-response pharmacodynamic evaluation of orally administered isradipine (PN-200-110) in hypertensive patients.
    McMahon FG; Vargas R; Ryan JR; Miller H; Faraday S
    J Clin Pharmacol; 1988 Jul; 28(7):664-6. PubMed ID: 2975291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antihypertensive effect of isradipine administered once or twice daily on ambulatory blood pressure.
    Lacourcière Y; Poirier L; Dion D; Provencher P
    Am J Cardiol; 1990 Feb; 65(7):467-72. PubMed ID: 2137666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and tolerability of nisoldipine coat-core formulation in the treatment of essential hypertension: The South African Multicenter ANCHOR Study. Ambulatory Nisoldipine Coat-Core Hypertension Outpatient Response (ANCHOR) Investigators.
    Opie LH; Müller FO; Myburgh DP; Rosendorff C; Sareli P; Seedat YK; Weich DJ; Luus HG
    Am J Hypertens; 1997 Mar; 10(3):250-60. PubMed ID: 9056681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isradipine: overall clinical experience in hypertension in the United States.
    Miller H
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S60-4. PubMed ID: 1695305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemodynamic response, safety, and efficacy of isradipine in the treatment of essential hypertension.
    Dahlöf B
    Am J Med; 1989 Apr; 86(4A):19-26. PubMed ID: 2523651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Felodipine, a new calcium antagonist, as monotherapy in mild or moderate hypertension. Cooperative study group.
    Drugs; 1987; 34 Suppl 3():139-48. PubMed ID: 2894973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of calcium antagonists to treat intra-operative hypertension--evaluation of efficacy and safety of a new dihydropyridine derivative, intravenous isradipine, during abdominal surgery.
    Edouard A; Dartayet B; Ruegg C; Samii K
    Eur J Anaesthesiol; 1991 Sep; 8(5):351-8. PubMed ID: 1834462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The calcium antagonist isradipine in the therapy of hypertension. A double-blind crossover comparison with nifedipine.
    Welzel D; Burger KJ
    Drugs; 1990; 40 Suppl 2():60-4. PubMed ID: 2150644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of essential hypertension with PN 200-110 (isradipine).
    Hamilton BP
    Am J Cardiol; 1987 Jan; 59(3):141B-145B. PubMed ID: 2949585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The long-term effect of isradipine in pindolol-treated patients.
    Dahlöf B; Andrén L; Eggertsen R; Jern S; Svensson A; Hansson L
    J Hypertens Suppl; 1987 Dec; 5(5):S567-70. PubMed ID: 2965231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multicenter comparison of isradipine and prazosin for treatment of essential hypertension.
    Swartz SL; Gonasun LM; McAllister RG; Thadani U
    Cardiovasc Drugs Ther; 1990 Apr; 4(2):413-7. PubMed ID: 2149512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of isradipine and captopril alone or in combination for the treatment of hypertension.
    Fitscha P; Meisner W; Hitzenberger G
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S12-4. PubMed ID: 1720478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicenter evaluation of efficacy, tolerability and safety of a new first-line antihypertensive drug, isradipine, in a Latin-American population.
    Gómez G; Melgarejo E; Narváez J; Gamarra G; Restrepo G; Acevedo L; Izurieta A
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):128S-130S. PubMed ID: 1827002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isradipine in Asian patients with hypertension.
    Zubair M; Karim S; Hussain S
    Drugs; 1990; 40 Suppl 2():26-9. PubMed ID: 2150636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.